Patent holdings for IPC class A61K 31/675

Total number of patents in this class: 4610

10-year publication summary

341
361
379
379
375
494
490
455
421
195
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Gilead Sciences, Inc.
2028
124
Antecip Bioventures II LLC
328
101
Iovance Biotherapeutics, Inc.
338
67
Merck Sharp & Dohme LLC
3741
46
Immunomedics, Inc.
267
42
The Regents of the University of California
19812
39
The Johns Hopkins University
5642
37
Novartis AG
10904
36
Bristol-myers Squibb Company
4892
36
Rigel Pharmaceuticals, Inc.
540
35
Psilo Scientific Ltd.
54
35
The United States of America, as represented by the Secretary, Department of Health and Human Services
2837
27
Achillion Pharmaceuticals, Inc.
164
23
Cipla Limited
467
23
Centre National de La Recherche Scientifique
10321
21
Turtle Bear Holdings, LLC
88
20
Allergan, Inc.
2362
19
Pharmacyclics LLC
238
18
Ascentage Pharma (Suzhou) Co., Ltd.
174
18
Hoffmann-La Roche Inc.
3379
17
Other owners 3826